Literature DB >> 25705728

Telehealth: the specialist perspective.

James Muir1.   

Abstract

BACKGROUND: Tele-Derm National is an online consultation and educational service in dermatology designed to meet the needs of doctors working in rural and remote Australia. In existence since 2003, it is hosted on the Rural and Remote Medical Education Online site, which is run by the Australian College of Rural and Remote Medicine.
OBJECTIVE: This article aims to explore the use and potential of store-and-forward teledermatology in the Australian context. DISCUSSION: Doctors who use this service can manage the majority of their patients without the need for a face-to-face appointment with a specialist dermatologist and deliver similar outcomes. Using store-and-forward technology rather than videoconferencing, this site provides specialist diagnosis and management advice year round. All cases are answered within 24 hours of being submitted. There are benefits in terms of increased availability, as well as reduced time, cost and professional isolation. However, uptake remains low, potentially because of a lack of awareness, increased workload for referring practitioners and lack of financial incentives.

Entities:  

Mesh:

Year:  2014        PMID: 25705728

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

Review 1.  Recent Directions in Telemedicine: Review of Trends in Research and Practice.

Authors:  Laurence S Wilson; Anthony J Maeder
Journal:  Healthc Inform Res       Date:  2015-10-31

2.  Provision of primary care by specialist physicians: a systematic review.

Authors:  Muhammad Jawad Hashim
Journal:  Fam Med Community Health       Date:  2020-02-25

Review 3.  Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications.

Authors:  Claudio Marasca; Maria Carmela Annunziata; Elisa Camela; Adriana Di Guida; Luigi Fornaro; Matteo Megna; Maddalena Napolitano; Cataldo Patruno; Luca Potestio; Gabriella Fabbrocini
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.